SomaLogic to Announce Second Quarter 2022 Financial Results

Rhea-AI Summary

SomaLogic announced it will report financial results for Q2 2022 on August 15, 2022, after market close. Management will hold an audio webcast at 4:30 p.m. ET to discuss these results. Interested parties can register to listen to the call online, and a replay will be available after the event. The company focuses on delivering actionable health-management information through its AI-driven proteomics technology. SomaLogic operates a CLIA certified and CAP accredited laboratory, although its SomaSignal™ tests are not FDA cleared or approved.

BOULDER, Colo. , July 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 15, 2022. Company management will host a corresponding audio webcast beginning at 4:30 p.m. ET.

Those interested in listening to the audio webcast should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A replay of the webcast will be available at https://investors.somalogic.com/.

About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

SomaSignal™ tests are developed and their performance characteristics determined by SomaLogic, Inc. They have neither been cleared or approved by the US Food and Drug Administration. SomaLogic operates a Clinical Laboratory Improvement Amendments (CLIA) certified, and College of American Pathologists (CAP) accredited laboratory.

Investor Contact
Lauren Glaser
lglaser@somalogic.com

Marissa Bych
Gilmartin Group LLC
marissa@gilmartinir.com

Media Contact
Emilia Costales
720-798-5054
ecostales@somalogic.com

FAQ

When will SomaLogic report its Q2 2022 financial results?

SomaLogic will report its Q2 2022 financial results on August 15, 2022.

What time will the SomaLogic Q2 2022 earnings call start?

The earnings call for Q2 2022 will begin at 4:30 p.m. ET.

Where can I listen to the SomaLogic financial results webcast?

You can register to listen to the SomaLogic financial results webcast online through their investor relations page.

Are SomaLogic's SomaSignal tests FDA approved?

No, SomaLogic's SomaSignal tests have neither been cleared nor approved by the FDA.

What type of laboratory does SomaLogic operate?

SomaLogic operates a CLIA certified and CAP accredited laboratory.